End-to-End Machine Learning-Driven Design of Targeted Monoclonal Antibodies
Exclusively Licensed
Invention type: Technology
/
Case number: #24595L
Researchers
Matthew Walsh
/
Rajmonda Caceres
/
Rafael Jaimes
/
Lin Li
/
Esther Wolf
/
Will Spaeth
/
Leslie Shing
/
Tristan Bepler
Departments: Lincoln Laboratory
Technology Areas: Artificial Intelligence (AI) and Machine Learning (ML) / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
end-to-end machine learning-driven design of proteins
Singapore | Pending -
end-to-end machine learning-driven design of proteins
Singapore | Pending -
end-to-end machine learning-driven design of proteins
United States of America | Pending
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.